Towards a point-of-care test for active tuberculosis: obstacles and opportunities

[1]  A. Szczepura,et al.  Point of care tests for tuberculosis (TB) : economic analysis report , 2012 .

[2]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[3]  Judith Mandelbaum-Schmid.  The global plan to stop TB 2011-2015 : transforming the fight towards elimination of tuberculosis , 2011 .

[4]  R. Peeling,et al.  The TDR Tuberculosis Specimen Bank: a resource for diagnostic test developers. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[5]  Eduardo Gotuzzo,et al.  Rapid molecular detection of tuberculosis and rifampin resistance. , 2010, The New England journal of medicine.

[6]  M. Perkins,et al.  Containment of Bioaerosol Infection Risk by the Xpert MTB/RIF Assay and Its Applicability to Point-of-Care Settings , 2010, Journal of Clinical Microbiology.

[7]  Conrad Bessant,et al.  Electronic-Nose Technology Using Sputum Samples in Diagnosis of Patients with Tuberculosis , 2010, Journal of Clinical Microbiology.

[8]  J. Zeng,et al.  A proteome-scale identification of novel antigenic proteins in Mycobacterium tuberculosis toward diagnostic and vaccine development. , 2010, Journal of proteome research.

[9]  R. Peeling,et al.  Point-of-care tests for diagnosing infections in the developing world. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  Philip L Felgner,et al.  Dynamic antibody responses to the Mycobacterium tuberculosis proteome , 2010, Proceedings of the National Academy of Sciences.

[11]  Virginia Pascual,et al.  An Interferon-Inducible Neutrophil-Driven Blood Transcriptional Signature in Human Tuberculosis , 2010, Nature.

[12]  R. McNerney,et al.  Field test of a novel detection device for Mycobacterium tuberculosis antigen in cough , 2010, BMC infectious diseases.

[13]  J. Kop,et al.  Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay , 2010, Journal of Clinical Microbiology.

[14]  Roland Zengerle,et al.  Microfluidic lab-on-a-foil for nucleic acid analysis based on isothermal recombinase polymerase amplification (RPA). , 2010, Lab on a chip.

[15]  L. Sechi,et al.  Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples , 2010, PloS one.

[16]  Karen Steingart,et al.  New and improved tuberculosis diagnostics: evidence, policy, practice, and impact , 2010, Current opinion in pulmonary medicine.

[17]  Graham Bothamley,et al.  Breath biomarkers of active pulmonary tuberculosis. , 2010, Tuberculosis.

[18]  P. Klatser,et al.  Serodiagnosis of tuberculous lymphadenitis using a combination of antigens. , 2010, Journal of infection in developing countries.

[19]  S. Kaufmann,et al.  The quest for biomarkers in tuberculosis. , 2010, Drug discovery today.

[20]  J. Lemaire,et al.  New diagnostics for tuberculosis: fulfilling patient needs first , 2010, Journal of the International AIDS Society.

[21]  R. McNerney.  Symposium: Point-of-care tests for tuberculosis. , 2010, Revista portuguesa de pneumologia.

[22]  T. Ndung’u,et al.  Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting , 2009, Cerebrospinal Fluid Research.

[23]  Ai Lin Chun,et al.  Nanoparticles offer hope for TB detection. , 2009, Nature nanotechnology.

[24]  Irene Ayakaka,et al.  Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology , 2009, Journal of Clinical Microbiology.

[25]  M. Dimairo,et al.  Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[26]  Po-Ren Hsueh,et al.  A simple gold nanoparticle probes assay for identification of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex from clinical specimens. , 2009, Molecular and cellular probes.

[27]  R. Chaisson,et al.  Diagnostic Accuracy of a Urine Lipoarabinomannan Test for Tuberculosis in Hospitalized Patients in a High HIV Prevalence Setting , 2009, Journal of acquired immune deficiency syndromes.

[28]  S. Lawn,et al.  Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease , 2009, AIDS.

[29]  Conrad Bessant,et al.  Evaluation of a combination of SIFT-MS and multivariate data analysis for the diagnosis of Mycobacterium bovis in wild badgers. , 2009, The Analyst.

[30]  M. Pai,et al.  Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[31]  Zhan Sun,et al.  Development and evaluation of a novel multiple-antigen ELISA for serodiagnosis of tuberculosis. , 2009, Tuberculosis.

[32]  Lauren E. Manning,et al.  The scent of Mycobacterium tuberculosis--part II breath. , 2009, Tuberculosis.

[33]  Henri Knobloch,et al.  Methodological Variability Using Electronic Nose Technology For Headspace Analysis , 2009 .

[34]  Henri Knobloch,et al.  Methodological variation in headspace analysis of liquid samples using electronic nose , 2009 .

[35]  F. Lwilla,et al.  African pouched rats for the detection of pulmonary tuberculosis in sputum samples. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[36]  Alimuddin Zumla,et al.  Biomarkers for tuberculosis disease status and diagnosis , 2009, Current opinion in pulmonary medicine.

[37]  Alimuddin Zumla,et al.  Biomarkers for tuberculosis disease activity, cure, and relapse. , 2009, The Lancet. Infectious diseases.

[38]  Qian Gao,et al.  Cross-Priming Amplification for Rapid Detection of Mycobacterium tuberculosis in Sputum Specimens , 2009, Journal of Clinical Microbiology.

[39]  N. Dendukuri,et al.  Performance of Purified Antigens for Serodiagnosis of Pulmonary Tuberculosis: a Meta-Analysis , 2008, Clinical and Vaccine Immunology.

[40]  Bernhard Weigl,et al.  Towards non- and minimally instrumented, microfluidics-based diagnostic devices. , 2008, Lab on a chip.

[41]  Peter G. Smith,et al.  Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  Donhee Ham,et al.  Chip–NMR biosensor for detection and molecular analysis of cells , 2008, Nature Medicine.

[43]  S. Chambers,et al.  The scent of Mycobacterium tuberculosis. , 2008, Tuberculosis.

[44]  Dirk Repsilber,et al.  Novel strategies to identify biomarkers in tuberculosis , 2008, Biological chemistry.

[45]  G. Bjune,et al.  A systematic review of delay in the diagnosis and treatment of tuberculosis , 2008, BMC public health.

[46]  K. Maquelin,et al.  Rapid Identification of Mycobacteria by Raman Spectroscopy , 2008, Journal of Clinical Microbiology.

[47]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[48]  Kemin Wang,et al.  Fluorescent Nanoparticle-Based Indirect Immunofluorescence Microscopy for Detection of Mycobacterium tuberculosis , 2007, Journal of biomedicine & biotechnology.

[49]  Guodong Liu,et al.  Disposable electrochemical immunosensor diagnosis device based on nanoparticle probe and immunochromatographic strip. , 2007, Analytical chemistry.

[50]  H. Wiker,et al.  Progress in Serodiagnosis of Mycobacterium tuberculosis Infection , 2007, Scandinavian journal of immunology.

[51]  K. Steingart,et al.  Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis , 2007, Expert review of anti-infective therapy.

[52]  K. Steingart,et al.  Commercial Serological Antibody Detection Tests for the Diagnosis of Pulmonary Tuberculosis: A Systematic Review , 2007, PLoS medicine.

[53]  R. C. Poller.  Reclamation of waste plastics and rubber: Recovery of materials and energy , 2007 .

[54]  S. Klamt,et al.  GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism , 2007, Genome Biology.

[55]  Mark D. Perkins,et al.  Operational Feasibility of Using Loop-Mediated Isothermal Amplification for Diagnosis of Pulmonary Tuberculosis in Microscopy Centers of Developing Countries , 2007, Journal of Clinical Microbiology.

[56]  Ying Zhang,et al.  HMDB: the Human Metabolome Database , 2007, Nucleic Acids Res..

[57]  J. Palomino,et al.  Tuberculosis 2007; from basic science to patient care , 2007 .

[58]  Olaf Tietje,et al.  Volatile biomarkers of pulmonary tuberculosis in the breath. , 2007, Tuberculosis.

[59]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[60]  Federico Girosi,et al.  Reducing the global burden of tuberculosis: the contribution of improved diagnostics , 2006, Nature.

[61]  J. Belisle,et al.  Disease State Differentiation and Identification of Tuberculosis Biomarkers via Native Antigen Array Profiling*S , 2006, Molecular & Cellular Proteomics.

[62]  M. Herbster,et al.  Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum , 2006, The Lancet.

[63]  Kristen L. Helton,et al.  Microfluidic Overview of Global Health Issues Microfluidic Diagnostic Technologies for Global Public Health , 2006 .

[64]  P. Baptista,et al.  Gold-nanoparticle-probe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. , 2006, Clinical chemistry.

[65]  Olaf Piepenburg,et al.  DNA Detection Using Recombination Proteins , 2006, PLoS biology.

[66]  Conrad Bessant,et al.  Prospects for Clinical Application of Electronic-Nose Technology to Early Detection of Mycobacterium tuberculosis in Culture and Sputum , 2006, Journal of Clinical Microbiology.

[67]  R. Chaisson,et al.  Delayed tuberculosis diagnosis and tuberculosis transmission. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[68]  M. Hoelscher,et al.  Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[69]  Angelika Niemz,et al.  Isothermal DNA amplification coupled with DNA nanosphere-based colorimetric detection. , 2005, Analytical chemistry.

[70]  John M Colford,et al.  In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and meta-regression , 2005, BMC Microbiology.

[71]  D. J. Marlin,et al.  Use of an Electronic Nose To Diagnose Mycobacterium bovis Infection in Badgers and Cattle , 2005, Journal of Clinical Microbiology.

[72]  Pierre Baldi,et al.  Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[73]  P. Andersen,et al.  Assessing the Serodiagnostic Potential of 35 Mycobacterium tuberculosis Proteins and Identification of Four Novel Serological Antigens , 2005, Journal of Clinical Microbiology.

[74]  G. Bai,et al.  Antigens secreted from Mycobacterium tuberculosis: Identification by proteomics approach and test for diagnostic marker , 2004, Proteomics.

[75]  David J. Galas,et al.  Isothermal reactions for the amplification of oligonucleotides , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[76]  S. Sivasubramaniam,et al.  Factors associated with patient and health system delays in the diagnosis of tuberculosis in South India. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[77]  M. Perkins,et al.  Diagnostic testing in the control of tuberculosis. , 2002, Bulletin of the World Health Organization.

[78]  Y. Mori,et al.  Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. , 2001, Biochemical and biophysical research communications.

[79]  Tuan Vo-Dinh,et al.  Nanosensors and biochips: frontiers in biomolecular diagnostics , 2001 .

[80]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[81]  P. Milligan,et al.  Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[82]  T. Notomi,et al.  Loop-mediated isothermal amplification of DNA. , 2000, Nucleic acids research.

[83]  I. Bastian,et al.  Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[84]  H. Banda,et al.  Care seeking behaviour and diagnostic processes in patients with smear-positive pulmonary tuberculosis in Malawi. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[85]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[86]  Y. Ikada,et al.  Biodegradable polyesters for medical and ecological applications , 2000 .

[87]  R. Dasari,et al.  Prospects for in vivo Raman spectroscopy. , 2000, Physics in medicine and biology.

[88]  V. Diwan,et al.  Delay and discontinuity--a survey of TB patients' search of a diagnosis in a diversified health care system. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[89]  D. Mitchison,et al.  Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[90]  R. O'brien,et al.  New tools for the diagnosis of tuberculosis: the perspective of developing countries. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[91]  Y. Amdekar,et al.  Multidrug resistant tuberculosis. , 1998, Indian pediatrics.

[92]  A. Telenti,et al.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.

[93]  Yukihiro Ozaki,et al.  Potential of Near-Infrared Fourier Transform Raman Spectroscopy in Food Analysis , 1992 .

[94]  P. Brennan,et al.  Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. , 1991, The Journal of biological chemistry.

[95]  R. Hayes,et al.  Impact of HIV on tuberculosis in Zambia: a cross sectional study. , 1990, BMJ.

[96]  T. M. Daniel.  Antibody and antigen detection for the immunodiagnosis of tuberculosis: why not? What more is needed? Where do we stand today? , 1988, The Journal of infectious diseases.